substances, 1. RECOMMENDS (a) that Member States of the Organization recognize officially the international standards and units enumerated in the list below, which supersedes the list recommended in resolution WHA3.8 : International Standards International Units Old tuberculin (Second Standard) 0.0100 (j.1 Purified protein derivative of avian tuberculin 0.0000726 mg Tetanus toxoid, plain 0.03 mg Diphtheria toxoid, plain 0.50 mg Diphtheria toxoid, adsorbed 0.75 mg Schick test toxin (diphtheria) 0.0042 mg Pertussis vaccine 1.5 mg Swine erysipelas vaccine 0.50 mg Newcastle disease vaccine (inactivated) 1.0 mg Tetanus antitoxin 0.3094 mg Diphtheria antitoxin 0.0628 mg Antidysentery serum (Shiga) 0.05 mg Gas-gangrene antitoxin (perfringens) (Clostridium welchii Type A antitoxin) (Fifth Standard) 0.3346 mg Gas-gangrene antitoxin (vibrion septique) (Third Standard) . . 0.118 mg Gas-gangrene antitoxin (oedematiens) (Second Standard) . . 0.1135 mg Gas-gangrene antitoxin (histolyticus) (Second Standard) . . 0.2 mg Gas-gangrene antitoxin (Sordelli) 0.1334 mg Staphylococcus a antitoxin (Second Standard) 0.2376 mg Scarlet fever streptococcus antitoxin 0.049 mg Antipneumococcus serum (Type 1) 0.0886 mg Antipneumococcus serum (Type 2) 0.0894 mg Anti-streptolysin O 0.0213 mg Anti-Q-fever serum 0.1017 mg Antirabies serum 1.0 mg Anti-A blood-typing serum 0.3465 mg Anti-B blood-typing serum 0.3520 mg Syphilitic human serum 3.617 mg Antipoliovirus serum (Type 1) 10.78 mg Antipoliovirus serum (Type 2) 10.46 mg Antipoliovirus serum (Type 3) 10.48 mg International Standards International Units Clostridium botulinum Type A antitoxin 0.1360 mg Clostridium botulinum Type B antitoxin 0.1740 mg Clostridium botulinum Type C antitoxin 0.0800 mg Clostridium botulinum Type D antitoxin 0.0121 mg Clostridium botulinum Type E antitoxin 0.0691 mg Naja antivenin 2.69 mg Clostridium wclchii (perfringens) Type B antitoxin 0.0137 mg Clostridium welchii (perfringens) Type D antitoxin 0.0657 mg Swine erysipelas serum (anti-N) 0.14 mg Anti-Brucella abortus serum 0.091 mg Anti-swine-fever serum 0.89 mg Penicillin (Second Standard) 0.0005988 mg Phenoxymethylpenicillin 0.00059 mg Streptomycin (Second Standard) 0.001282 mg Dihydrostreptomycin 0.001316 mg Bacitracin (Scond Standard) 0.01351 mg Tetracycline 0.00101 mg Chlortetracycline 0.001 mg Oxytetracycline 0.00111 mg Erythromycin 0.001053 mg Polymyxin B 0.000127 mg Nystatin 0.000333 mg Amphotericin B 0.001064 mg Vancomycin 0.000993 mg Oleandomycin 0.001176 mg Oxytocic, vasopressor and anti-diuretic substances (Third Standard) 0.5 mg Prolactin (Second Standard) 0.04545 mg Corticotrophin (Third Standard) 1.0 mg Thyrotrophin 13.5 mg Growth hormone 1.0 mg Serum gonadotroph^ 0.25 mg Chorionic gonadotrophin (Second Standard) 0.001279 mg Insulin (Fourth Standard) 0.04167 mg Heparin (Second Standard) 0.0077 mg Vitamin D3 (Second Standard) 0.000025 mg Hyaluronidase 0.1 mg Digitalis (Third Standard) 76.0 mg (,b) that these standards and units or their equivalents be cited in the relevant national pharmacopoeias ; (c) that where applicable, these standards and units or their equivalents be recognized in relevant national regulations; (d) that in those countries which do not possess a national pharmacopoiea or national standards the potency appearing on the labels of biological products be expressed in international units; 2. INVITES the Director-General to inquire periodically from Members regarding the use being made of international standards in their countries. Handb. Res., 7th ed., 1.3.1.1 Eighth plenary meeting, 12 May 1965 (Committee on Programme and Budget, second reportJ